Literature DB >> 2032419

Inhibition of lung colonization at two different steps in the metastatic sequence.

C J Aslakson1, D McEachern, D H Conaway, F R Miller.   

Abstract

Two immunomodulatory protocols were evaluated for their ability to inhibit lung colonization by mouse mammary tumor line 4T07. Preimmunization with tumor cells or pretreatment with poly I:C were equally effective at inhibiting lung colonization but a clonogenic tumor cell assay demonstrated that the treatments reduced tumor cell burden at different steps during the metastatic process. Poly I:C pretreatment accelerated tumor cell clearance based on the recovery of clonogenic tumor cells from lungs dispersed within 6 h post-arrest. Preimmunization inhibited the subsequent replication of tumor cells which survived and established in the lung, as indicated by the expansion of clonogenic cell numbers between 1 day and 7 days post-arrest. Histologic examination of serial sections of lungs demonstrated that very few (6%) of the tumor cells were extravascular 6 h post-tumor cell injection. By 24 h and 168 h the percentages of tumor cells which were extravascular had increased to 62% and 86%, respectively. Thus, poly I:C pretreatment appears to enhance killing of tumor cells prior to extravasation, whereas preimmunization appears to inhibit tumor cells after extravasation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032419     DOI: 10.1007/bf01756385

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  16 in total

1.  Effect of host sensitization on patterns of metastasis.

Authors:  D Glaves; L Weiss
Journal:  Transplant Proc       Date:  1975-06       Impact factor: 1.066

2.  Method for quantitating tumor cell removal and tumor cell-invasive capacity in experimental metastases.

Authors:  L A Liotta; C DeLisi
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

3.  A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors.

Authors:  J Vaage
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

4.  Use of drug resistance markers to recover clonogenic tumor cells from occult metastases in host tissues.

Authors:  F R Miller; D J McInerney; C Rogers; D R Aitken; W Z Wei
Journal:  Invasion Metastasis       Date:  1986

5.  Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor.

Authors:  F R Miller; G H Heppner
Journal:  J Natl Cancer Inst       Date:  1979-12       Impact factor: 13.506

6.  Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability.

Authors:  F R Miller; B E Miller; G H Heppner
Journal:  Invasion Metastasis       Date:  1983

7.  Biological diversity in metastatic neoplasms: origins and implications.

Authors:  I J Fidler; I R Hart
Journal:  Science       Date:  1982-09-10       Impact factor: 47.728

8.  Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.

Authors:  B E Miller; F R Miller; D Wilburn; G H Heppner
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

9.  Efficient recovery of clonogenic stem cells from solid tumors and occult metastatic deposits.

Authors:  B E Miller; C J Aslakson; F R Miller
Journal:  Invasion Metastasis       Date:  1990

10.  Host treatments affecting artificial pulmonary metastases: interpretation of loss of radioactively labelled cells from lungs.

Authors:  J M Brown; E T Parker
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

View more
  5 in total

1.  Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Authors:  Julianne L Holleran; Carson J Miller; Nancy L Edgehouse; Theresa P Pretlow; Lloyd A Culp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

3.  Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade.

Authors:  Saeed S Akhand; Zian Liu; Stephen C Purdy; Ammara Abdullah; Hang Lin; Gregory M Cresswell; Timothy L Ratliff; Michael Wendt
Journal:  Cancer Immunol Res       Date:  2020-10-22       Impact factor: 11.151

4.  Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.

Authors:  B E Miller; F R Miller; T Machemer; G H Heppner
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

5.  Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness.

Authors:  Alexandra Avgustinova; Marjan Iravani; David Robertson; Antony Fearns; Qiong Gao; Pamela Klingbeil; Andrew M Hanby; Valerie Speirs; Erik Sahai; Fernando Calvo; Clare M Isacke
Journal:  Nat Commun       Date:  2016-01-18       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.